Branched‐chain amino acid to tyrosine ratio is an essential pre‐treatment factor for maintaining sufficient treatment intensity of lenvatinib in patients with hepatocellular carcinoma

2020 ◽  
Vol 27 (12) ◽  
pp. 913-921
Author(s):  
Yuji Eso ◽  
Shigeharu Nakano ◽  
Masako Mishima ◽  
Soichi Arasawa ◽  
Eriko Iguchi ◽  
...  
2011 ◽  
Vol 29 (3) ◽  
pp. 326-332 ◽  
Author(s):  
Sosuke Hayaishi ◽  
Hobyung Chung ◽  
Masatoshi Kudo ◽  
Emi Ishikawa ◽  
Masahiro Takita ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document